Cite
HARVARD Citation
Rahma, O. et al. (n.d.). 808 Exploring resistance mechanism to pembrolizumab and ang-2 inhibitor trebananib (NCT03239145) using high-dimensional single-cell mass cytometry (CyTOF). Journal for immunotherapy of cancer. pp. A483-A484. [Online].